Insider Transactions last 24 months for BioCryst Pharmaceuticals, Inc.  -  NSDQ: BCRX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Milano VincentDirector08/29/2025AADirectCOM676$8.31$5,617.5690,436
Frank StevenDirector08/29/2025AADirectCOM1,353$8.31$11,243.4316,052
Mckee Amy EDirector08/29/2025AADirectCOM676$8.31$5,617.5641,007
Heggie TheresaDirector08/13/2025DSDirectCOM70,000$8.51$595,868.0065,352
Heggie TheresaDirector08/13/2025AMDirectCOM40,000$5.41$216,400.00135,352
Heggie TheresaDirector08/13/2025AMDirectCOM30,000$2.91$87,300.0095,352
Ghias BabarCFO & Head of Corp Development07/24/2025AADirectCOM147,000$0.00$0.00147,000
Frank StevenDirector06/12/2025AADirectCOM12,500$0.00$0.0014,699
Galson Steven KDirector06/12/2025AADirectCOM12,500$0.00$0.0024,991
Heggie TheresaDirector06/12/2025AADirectCOM12,500$0.00$0.0065,352
Hutson Nancy JDirector06/12/2025AADirectCOM12,500$0.00$0.0099,138
Levin Alan GDirector06/12/2025AADirectCOM12,500$0.00$0.0064,271
Mckee Amy EDirector06/12/2025AADirectCOM12,500$0.00$0.0040,331
Milano VincentDirector06/12/2025AADirectCOM12,500$0.00$0.0089,760
Sanders MachelleDirector06/12/2025AADirectCOM12,500$0.00$0.0040,242
Frank StevenDirector05/30/2025AADirectCOM333$10.75$3,579.752,199
Milano VincentDirector05/30/2025AADirectCOM523$10.75$5,622.2577,260
Frank StevenDirector05/02/2025AADirectCOM1,866$0.00$0.001,866
Thackray Helen M.Chief R&D Officer03/31/2025DFDirectCOM7,525$7.50$56,437.50377,318
Milano VincentDirector02/28/2025AADirectCOM653$8.61$5,622.3376,737
Stonehouse Jon PPresident & CEO12/20/2024AGIndirectCOM10,000$0.00$0.0030,000
Stonehouse Jon PPresident & CEO12/20/2024AGIndirectCOM10,000$0.00$0.0030,000
Stonehouse Jon PPresident & CEO12/20/2024DGDirectCOM20,000$0.00$0.001,429,109
Stonehouse Jon PPresident & CEO12/19/2024DFDirectCOM14,010$7.39$103,533.901,449,109
Stonehouse Jon PPresident & CEO12/19/2024AADirectCOM362,100$0.00$0.001,463,119
1   2  3  4  Next Last  You are at page 1 of 4 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel